Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_assertion wasGeneratedBy ECO_0000203 NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_assertion wasDerivedFrom befree-20150227 NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_assertion SIO_000772 16245282 NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_assertion evidence source_evidence_literature NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.
- NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_assertion description "[A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817878.RA3zgs_UPCs5OuJQ1ziACFyrCkcQalfvIEGis-mfKkUWE130_provenance.